Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2024
T Cell Exhaustion Markers in Multiple Myeloma Patients are Lower After Physical Activity InterventionJanine M Joseph, Michaela Hillengass, Rikki Cannioto, et al.
Oncotarget|January 20, 2018
Combined surgery and radiation improves survival of tonsil squamous cell cancersAnurag K Singh, Christina Mimikos, Adrienne Groman, et al.
Hormones & Cancer|March 5, 2013
Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genesJosephia R Muindi, Araba A Adjei, Zengru R Wu, et al.
The Laryngoscope|November 4, 2016
Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011Mary E Platek, Vijayvel Jayaprakash, Vishal Gupta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 10, 2018
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and ToxicityGeorge L Chen, Theresa Hahn, Gregory E Wilding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870)Roberto Pili, David I Quinn, Hans J Hammers, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influxShipra Gandhi, Mateusz Opyrchal, Melissa J Grimm, et al.
Blood Advances|November 14, 2022
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCLPallawi Torka, Adrienne Groman, Jerry Wong, et al.
Clinical Journal of Oncology Nursing|July 25, 2017
Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer CentersJeannette Jackson-Rose, Judith Del Monte, Adrienne Groman, et al.
Frontiers in Oncology|August 22, 2022
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLCRachel Evans, Kelvin Lee, Paul K Wallace, et al.
Pageof 8